EUCTR2017-002155-28-FR进行中（未招募）1 期
Evaluation of allopurinol treatment for autistic disorders and epilepsy in adenylosuccinate lyase deficiency (ADSL) - ADS
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-child (minimum age 18 months) or adult with adenylosuccinate lyase (ADSL) deficiency confirmed by quantification of SAICAr and urinary S-adenosine,
- •-consent of the patient, parents or legal representative,
- •-Beneficiary of social security coverage (affiliated or entitled).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 2
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 6
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-refusal by the child, his parents or his representative,
- •-known allergy to allopurinol or to one of the constituents of the product (notably lactose),
- •-Patients treated with Antipurines (azathioprine, mercaptopurine).
- •-renal insufficiency characterized by creatine clearance < 80 mL/min/1.73m²,
- •-breastfeeding,
- •-pregnancy.
研究者
相似试验
已完成
2 期
Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase DeficiencyAdenylosuccinate Lyase DeficiencyNCT03776656Assistance Publique - Hôpitaux de Paris8
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos
已完成
3 期
Evaluation of allopurinol efficacy in patients with nonalcoholic fatty liver diseasenonalcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT20160920029889N1Oroumia University of Medical Sciences44
招募中
Unknown
Allopurinol as an Adjunctive Therapy in Patients with Bipolar ManiaCTRI/2023/10/058864Central Institute Of Psychiatry
已完成
不适用
A pilot study of high dose allopurinol in the management of gout:GoutInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12606000276550isa Stamp100